Difference between revisions of "Part:BBa K4765012"
(→Characterization) |
|||
| (One intermediate revision by one other user not shown) | |||
| Line 14: | Line 14: | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
| − | We performed codon optimization on [https://parts.igem.org/Part:BBa_K4273008 BBa_K4273008 | + | We performed codon optimization on [https://parts.igem.org/Part:BBa_K4273008 BBa_K4273008] specifically for the ''Escherichia coli'' K12 strain, resulting in the creation of this part. The enzyme MysC catalyzes the third reaction involved in the biosynthesis of Mycosporine-like amino acids (MAAs) within ''E. coli''. |
| − | + | ||
===Characterization=== | ===Characterization=== | ||
| Line 34: | Line 33: | ||
| <html><img style="width:640px" src="https://static.igem.wiki/teams/4765/wiki/results-wyj/mysverification.png" alt="contributed by Fudan iGEM 2023"></html> | | <html><img style="width:640px" src="https://static.igem.wiki/teams/4765/wiki/results-wyj/mysverification.png" alt="contributed by Fudan iGEM 2023"></html> | ||
|- | |- | ||
| − | | '''Figure 3. Plates displaying transformed E. coli after anti-UV assay.''' | + | | '''Figure 3. Plates displaying transformed ''E. coli'' after anti-UV assay.''' |
|} | |} | ||
Latest revision as of 15:19, 12 October 2023
MysC codon optimized
Contents
Introduction
An ATP-grasp enzyme MysC converts 4-DG to mycosporineglysine (MG) by introducing L-Glycine to 4-DG at C3[1].
|
| Figure 1. The biosynthetic pathway of shinorine, porphyra-334, palythine-Ser, and palythine-Thr |
Usage and Biology
We performed codon optimization on BBa_K4273008 specifically for the Escherichia coli K12 strain, resulting in the creation of this part. The enzyme MysC catalyzes the third reaction involved in the biosynthesis of Mycosporine-like amino acids (MAAs) within E. coli.
Characterization
Anti-UV Survival Assay
We employed the Colony-Forming Unit (CFU) assay. After plasmid transformation and plating, we shielded one/half of the agar plate from UV light using a black cloth, while the other one/half was exposed to UV irradiation (6W power) with wavelengths of 254 nm and 365 nm for 10 seconds.
|
| Figure 2. Anti-UV Assay. |
Our experiments demonstrated that introducing three or four of the five enzymes from the MAA biosynthetic pathway into E. coli did not yield a significant enhancement in the bacterium's UV resistance. We postulate that this lack of effect may arise from two factors: Firstly, the synthetic pathway may not play a pivotal role amidst the numerous routes involved in MAA synthesis. Secondly, to augment MAA levels within E. coli through protein expression in the pathway, additional substrates like ATP and amino acids would likely be required in the reaction.
|
| Figure 3. Plates displaying transformed E. coli after anti-UV assay. |
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI.rc site found at 736
References
- ↑ Chen, M., Rubin, G. M., Jiang, G., Raad, Z., & Ding, Y. (2021). Biosynthesis and heterologous production of mycosporine-like amino acid palythines. The Journal of Organic Chemistry, 86(16), 11160–11168.